Taiwan FDA registration c647e9637cded1cae80ab101dd64463d

"Imno Consester" extractable nuclear antigen autoantibody screening enzyme immunotest set

TW: "伊姆諾康塞斯特" 可萃取核抗原自體抗體篩選酵素免疫測試試劑組

Taiwan·Risk Class 2·IMMUNO CONCEPTS NA LTD·Registered Dec 22, 2005 – Dec 22, 2015Cancelled

Registration details

Analysis ID: c647e9637cded1cae80ab101dd64463d
Customs Code: DHA00601571608

Company information

Manufacturer: IMMUNO CONCEPTS NA LTD
Manufacturer Country: United States
Authorized Representative: GRANT TECHNOLOGY CO., LTD.

Product details

Intended Use: 偵測可萃取核抗原(extractable nuclear antigens, ENA)人體血漿中對抗Sm(Smith)、RNP、SS-A(Ro)、SS-B(La)、Scl-70與Jo-1的抗體.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5100 抗核抗體免疫試驗系統
Import Information: import

Dates and status

Registration Date: Dec 22, 2005
Expiry Date: Dec 22, 2015
Cancellation Date: May 10, 2018

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for "Imno Consester" extractable nuclear antigen autoantibody screening enzyme immunotest set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c647e9637cded1cae80ab101dd64463d and manufactured by IMMUNO CONCEPTS NA LTD. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.